QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
NASDAQ:SCLX

Scilex - SCLX Stock Forecast, Price & News

$8.69
-0.12 (-1.36%)
(As of 01/30/2023 04:21 PM ET)
Add
Compare
Today's Range
$8.17
▼
$9.99
50-Day Range
$2.87
▼
$11.32
52-Week Range
$2.87
▼
$11.69
Volume
347,730 shs
Average Volume
531,233 shs
Market Capitalization
$1.23 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SCLX stock logo

About Scilex (NASDAQ:SCLX) Stock

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trail for the treatment of low back pain; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.

Receive SCLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scilex and its competitors with MarketBeat's FREE daily newsletter.

SCLX Stock News Headlines

January 14, 2023 | marketbeat.com
MarketBeat: Week in Review 01/09-01/13 (SCLX)
Markets are looking for direction in early trading before a holiday weekend. Here are some of the popular stories MarketBeat analysts were covering this week.
January 12, 2023 | marketbeat.com
Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move (SCLX)
Sorrento Therapeutics is on the move following preliminary results from its subsidiary Scilex. Scilex is making money with the company's 1st product to market
January 30, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
January 28, 2023 | americanbankingnews.com
Scilex (NASDAQ:SCLX) Trading 9.5% Higher
January 28, 2023 | finance.yahoo.com
Why Shares of Scilex Soared This Week
January 25, 2023 | americanbankingnews.com
Scilex (NASDAQ:SCLX) Stock Price Down 5%
January 24, 2023 | seekingalpha.com
A SPAC, Spinoff, And Short Squeeze Walk Into A Bar
January 24, 2023 | seekingalpha.com
Red Flags Waving As Scilex' Surprisingly High Valuation Starts To Correct
January 30, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
January 14, 2023 | barrons.com
Scilex Holding Co.
November 17, 2022 | seekingalpha.com
SCLX Scilex Holding Company
November 17, 2022 | ca.finance.yahoo.com
Loss-making Scilex Holding (NASDAQ:SCLX) sheds a further US$255m, taking total shareholder losses to 13% over 1 year
See More Headlines
Receive SCLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scilex and its competitors with MarketBeat's FREE daily newsletter.

SCLX Company Calendar

Today
1/30/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SCLX
CUSIP
N/A
CIK
1820190
Web
www.scilexholding.com
Phone
650 516 4310
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$780,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-16.72%
Return on Assets
1.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.20
Quick Ratio
0.20

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.03 per share
Price / Cash Flow
330.03
Book Value
($0.30) per share
Price / Book
-28.97

Miscellaneous

Outstanding Shares
141,350,000
Free Float
113,079,000
Market Cap
$1.23 billion
Optionable
Not Optionable
Beta
-0.35

Key Executives

  • Mr. Jaisim Shah (Age 63)
    Pres, CEO & Director
    Comp: $869.79k
  • Mr. Suresh K. Khemani (Age 63)
    Sr. VP & Chief Commercial Officer
    Comp: $456.82k
  • Dr. Dmitri V. Lissin M.D. (Age 64)
    Sr. VP & Chief Medical Officer
    Comp: $528.83k
  • Dr. Henry H. Ji Ph.D. (Age 59)
    Exec. Chairman
  • Ms. Elizabeth Adkins Czerepak M.B.A. (Age 67)
    Exec. VP, CFO, Chief Bus. Officer & Sec.
  • Dr. Suketu D. Desai Ph.D. (Age 58)
    Chief Technical Officer & Sr. VP
  • Mr. Steven F. Lincoln J.D.
    Gen. Counsel & Chief Compliance Officer

Key Competitors

View All Competitors













SCLX Stock - Frequently Asked Questions

How have SCLX shares performed in 2023?

Scilex's stock was trading at $3.99 at the beginning of the year. Since then, SCLX shares have increased by 111.5% and is now trading at $8.44.
View the best growth stocks for 2023 here.

What is Scilex's stock symbol?

Scilex trades on the NASDAQ under the ticker symbol "SCLX."

How do I buy shares of Scilex?

Shares of SCLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Scilex's stock price today?

One share of SCLX stock can currently be purchased for approximately $8.44.

How much money does Scilex make?

Scilex (NASDAQ:SCLX) has a market capitalization of $1.19 billion.

How can I contact Scilex?

Scilex's mailing address is 1 Harbourfront Avenue #16-06 Keppel Bay Tower, Singapore U0, 098632. The official website for the company is www.scilexholding.com. The company can be reached via phone at 650 516 4310.

This page (NASDAQ:SCLX) was last updated on 1/30/2023 by MarketBeat.com Staff